Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant's bundle of recent acquisitions in a Monday interview with CNBC's Jim Cramer, and indicated the company is in a transformative stage."We are writing the next chapter of this company," Boerner said. "And we've got real financial strength that has enabled us to go and actually bring innovation in to the company from outside. And that's what we've done with these most recent deals."Bristol-Myers Squibb announced three multi-billion-dollar ...